A randomized, double-blind, parallel group, placebo-controlled study evaluating the efficacy and safety of tadalafil (5mg and 20mg) administered once daily to subjects with mild to moderate hypertension
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2006
At a glance
- Drugs Tadalafil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 29 Oct 2005 New trial record.